A delegation of the 'alliance' led by its core committee members Dr G S Grewal and Dr Arun Mitra met the chairman of the National Pharmaceutical Pricing Authority (NPPA) here today.
They apprised him about the alleged loot resorted to by several implant manufacturers in connivance with some doctors and hospitals.
The doctors explained how the nexus was resorting to "wanton loot" by inflating the MRP prices while giving these to the hospitals at a far less price. The hospitals in turn charge the unsuspecting patients the MRP and share the extra profit which is quite substantial with the manufacturers and the suppliers.
"In some cases, some influential patients may be given discount up to 10 per cent but still the profit margin is very high. This is in a way excess charge levied on the patient," Dr Grewal said.
The doctors proposed that the price of the implants used in health care should be calculated as per cost accountancy only. No other method can lead to justifiable fixation of prices of drugs.
The difference between the actual price of the drugs and the MRP should not be more than 20 per cent while at present it is up to 700-800 per cent in some cases. They said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
